EP1539997A4 - Dosage a haut rendement de proliferation de souches hematopoietiques et de cellules progenitrices - Google Patents

Dosage a haut rendement de proliferation de souches hematopoietiques et de cellules progenitrices

Info

Publication number
EP1539997A4
EP1539997A4 EP03793209A EP03793209A EP1539997A4 EP 1539997 A4 EP1539997 A4 EP 1539997A4 EP 03793209 A EP03793209 A EP 03793209A EP 03793209 A EP03793209 A EP 03793209A EP 1539997 A4 EP1539997 A4 EP 1539997A4
Authority
EP
European Patent Office
Prior art keywords
cell proliferation
hematopoietic stem
progenitor cell
throughput assay
throughput
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03793209A
Other languages
German (de)
English (en)
Other versions
EP1539997A2 (fr
Inventor
Ivan N Rich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rich Ivan N
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP1539997A2 publication Critical patent/EP1539997A2/fr
Publication of EP1539997A4 publication Critical patent/EP1539997A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP03793209A 2002-08-21 2003-08-21 Dosage a haut rendement de proliferation de souches hematopoietiques et de cellules progenitrices Withdrawn EP1539997A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40497202P 2002-08-21 2002-08-21
US404972P 2002-08-21
PCT/US2003/026167 WO2004018996A2 (fr) 2002-08-21 2003-08-21 Dosage a haut rendement de proliferation de souches hematopoietiques et de cellules progenitrices

Publications (2)

Publication Number Publication Date
EP1539997A2 EP1539997A2 (fr) 2005-06-15
EP1539997A4 true EP1539997A4 (fr) 2007-04-25

Family

ID=31946791

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03793209A Withdrawn EP1539997A4 (fr) 2002-08-21 2003-08-21 Dosage a haut rendement de proliferation de souches hematopoietiques et de cellules progenitrices

Country Status (4)

Country Link
EP (1) EP1539997A4 (fr)
AU (1) AU2003258319B2 (fr)
CA (1) CA2496251A1 (fr)
WO (1) WO2004018996A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7989178B2 (en) 2001-01-29 2011-08-02 Hemogenix, Inc. Colony assay miniaturization with enumeration output
US7354730B2 (en) 2002-01-29 2008-04-08 Hemogenix, Inc. High-throughput assay of hematopoietic stem and progenitor cell proliferation
CA2437084C (fr) 2001-01-29 2010-12-21 Ivan N. Rich Dosage a haut rendement de cellules souches d'une souche hematopoietique et proliferation de cellules progenitrices
US7666615B2 (en) 2001-01-29 2010-02-23 Hemogenix, Inc. High-throughput assay of hematopoietic stem and progenitor cell proliferation
WO2013038341A1 (fr) * 2011-09-13 2013-03-21 Basf Se Moyens et méthodes pour évaluer la toxicité hématopoïétique
TWI848906B (zh) * 2017-03-15 2024-07-21 美商歐卡生物系統公司 用於造血幹細胞移植的組合物及方法
EP4004192B1 (fr) * 2019-07-24 2024-10-23 Miltenyi Biotec B.V. & Co. KG Analyse d'identification de cellules formant des colonies
CN115927169B (zh) * 2022-10-11 2023-08-11 再造再生医学科技(杭州)有限公司 用于扩增cd34+造血干细胞的培养液和体外扩增cd34+造血干细胞的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998021313A1 (fr) * 1996-11-08 1998-05-22 Otsuka Pharmaceutical Co., Ltd. Procede pour la mise en culture de cellules souches hematopoïetiques
WO2003004995A2 (fr) * 2001-01-29 2003-01-16 Rich Ivan N Dosage a haut rendement de cellules souches d'une souche hematopoietique et proliferation de cellules progenitrices

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283179A (en) * 1990-09-10 1994-02-01 Promega Corporation Luciferase assay method
US5733541A (en) * 1995-04-21 1998-03-31 The Regent Of The University Of Michigan Hematopoietic cells: compositions and methods
US5854010A (en) * 1997-03-10 1998-12-29 Denison; Michael S. Bioassay for detecting 2,3,7,8-tetrachlorodibenzo-para-dioxin and TCDD-like compounds and novel recombinant cell line useful therefor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998021313A1 (fr) * 1996-11-08 1998-05-22 Otsuka Pharmaceutical Co., Ltd. Procede pour la mise en culture de cellules souches hematopoïetiques
WO2003004995A2 (fr) * 2001-01-29 2003-01-16 Rich Ivan N Dosage a haut rendement de cellules souches d'une souche hematopoietique et proliferation de cellules progenitrices

Non-Patent Citations (13)

* Cited by examiner, † Cited by third party
Title
BALLMAIER M ET AL: "C-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia", BLOOD, W.B.SAUNDERS COMPANY, ORLANDO, FL, US, vol. 97, no. 1, 2001, pages 139 - 146, XP002980535, ISSN: 0006-4971 *
BRADLEY T R ET AL: "THE EFFECT OF OXYGEN TENSION ON HAEMOPOIETIC AND FIBROBLAST CELL PROLIFERATION IN VITRO", JOURNAL OF CELLULAR PHYSIOLOGY, LISS, NEW YORK, NY, US, vol. 97, no. 3 PT 2 SUPPL1, December 1978 (1978-12-01), pages 517 - 522, XP009080296, ISSN: 0021-9541 *
BULANOVA E G ET AL: "Bioluminescent assay for human lymphocyte blast transformation", IMMUNOLOGY LETTERS, vol. 46, no. 1-2, 1995, pages 153 - 155, XP009048894, ISSN: 0165-2478 *
CROUCH S P M ET AL: "THE USE OF ATP BIOLUMINESCENCE AS A MEASURE OF CELL PROLIFERATION AND CYTOTOXICITY", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 160, no. 1, 1993, pages 81 - 88, XP002059949, ISSN: 0022-1759 *
DATABASE WPI Week 1998, Derwent World Patents Index; AN 1998-297920, XP002424190, "Culture method kit haematopoietic stem cell culture cell adhesive culture vessel presence stem cell growth factor" *
FUJISAKI T ET AL: "Rapid differentiation of a rare subset of adult human lin(-)CD34(-)CD38(-) cells stimulated by multiple growth factors in vitro.", BLOOD 15 SEP 1999, vol. 94, no. 6, 15 September 1999 (1999-09-15), pages 1926 - 1932, XP002424141, ISSN: 0006-4971 *
GABBIANELLI M ET AL: "Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors.", BLOOD 1 SEP 1995, vol. 86, no. 5, 1 September 1995 (1995-09-01), pages 1661 - 1670, XP002424142, ISSN: 0006-4971 *
KATAYAMA YOSHIO ET AL: "Replating potential of colony-forming units of granulocytes/macrophages (CFU-GM) expanded ex vivo by stem cell factor, interleukin (IL)-3, IL-6, granulocyte colony-stimulating factor, erythropoietin with or without thrombopoietin", INTERNATIONAL JOURNAL OF HEMATOLOGY, vol. 68, no. 2, August 1998 (1998-08-01), pages 157 - 168, XP009048892, ISSN: 0925-5710 *
LEMOLI ROBERTO M ET AL: "Interleukin-9 stimulates the proliferation of human myeloid leukemic cells", BLOOD, vol. 87, no. 9, 1996, pages 3852 - 3859, ISSN: 0006-4971 *
RICH I N ET AL: "THE EFFECT OF REDUCED OXYGEN TENSION ON COLONY FORMATION OF ERYTHROPOIETIC CELLS IN VITRO", BRITISH JOURNAL OF HAEMATOLOGY, OXFORD, GB, vol. 52, no. 4, December 1982 (1982-12-01), pages 579 - 588, XP009080297, ISSN: 0007-1048 *
RICH IVAN N ET AL: "HALO - A Multifunctional Colony-Forming-Based Assay Platform for Drug Development and Basic and Clinical Research.", BLOOD, vol. 100, no. 11, 16 November 2002 (2002-11-16), & 44TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY; PHILADELPHIA, PA, USA; DECEMBER 06-10, 2002, pages Abstract No. 2434, XP009048843, ISSN: 0006-4971 *
SHIOHARA MASAAKI ET AL: "24-Oxo metabolites of vitamin D3 analogues: Disassociation of their prominent antileukemic effects from their lack of calcium modulation", CANCER RESEARCH, vol. 61, no. 8, 15 April 2001 (2001-04-15), pages 3361 - 3368, ISSN: 0008-5472 *
SOTTONG P R ET AL: "Measurement of T-lymphocyte responses in whole-blood cultures using newly synthesized DNA and ATP.", CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY. MAR 2000, vol. 7, no. 2, March 2000 (2000-03-01), pages 307 - 311, XP002331295, ISSN: 1071-412X *

Also Published As

Publication number Publication date
WO2004018996A3 (fr) 2004-06-10
EP1539997A2 (fr) 2005-06-15
AU2003258319A1 (en) 2004-03-11
AU2003258319B2 (en) 2009-09-17
CA2496251A1 (fr) 2004-03-04
WO2004018996A2 (fr) 2004-03-04

Similar Documents

Publication Publication Date Title
HK1090086A1 (en) Modulation of stem and progenitor cell differentiation, assays, and uses thereof
EP1539972A4 (fr) Procedes visant a induire la differenciation de cellules embryonnaires et utilisations associees
TWI372624B (en) Azaindoles useful as inhibitors of jak and other protein kinases
AU2003287324A8 (en) Gene expression systems and recombinant cell lines
PL374023A1 (en) Inhibitors of jak and cdk2 protein kinases
EP1974018A4 (fr) Très petites cellules souches de type embryoniques (vsel) et procédés d'isolation et d'utilisation correspondant
AU2003302701A8 (en) Method of dynamically culturing embryonic stem cells
PL375355A1 (en) Novel lipases and uses thereof
AU2003273332A8 (en) Method of enhancing proliferation and/or hematopoietic differentiation of stem cells
AU2002360684A8 (en) Fabrication of surfaces with reduced protein adsorption and/or cell adhesion
SI2332940T1 (sl) Azaindoli, uporabni kot inhibitorji jak in drugih protein-kinaz
AU2003290432A8 (en) T cell activating gene
AU2003216822A8 (en) Stem cell culture
PL376085A1 (en) Methods of increasing platelet and hematopoietic stem cell production
AU2003223124A1 (en) Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same
EP1687411A4 (fr) Identification et isolation de cellules souches hematopoietiques
EP1539997A4 (fr) Dosage a haut rendement de proliferation de souches hematopoietiques et de cellules progenitrices
EP1557461A4 (fr) Composition destinee a la culture de cellules souches pluripotentes et utilisation de cette derniere
AU2003250519A8 (en) Ex-vivo expansion of hematopoietic stem cell populations in mononuclear cell cultures
IL165969A0 (en) Medium for culturing aurologous human progenitor stem cells and applications thereof
AU2003287521A8 (en) Pluripotent cells from monocytes, and methods of making and using pluripotent cells
IL146970A0 (en) Migration of haematopoietic stem cells and progenitor cells to the liver
IL187804A0 (en) Oligonucleotides stimulatory of the mesenchymal stem cell proliferation and uses thereof
EP1788089A4 (fr) Sequence d'un gene de l-rhamnose isomerase thermotolerante et utilisation de celle-ci
EP1496122A4 (fr) Gene resistant au genre meloidogyne, et utilisation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050317

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20070327

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/66 20060101ALI20070319BHEP

Ipc: G01N 33/50 20060101AFI20070319BHEP

17Q First examination report despatched

Effective date: 20070924

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: RICH, IVAN N.

RIN1 Information on inventor provided before grant (corrected)

Inventor name: RICH, IVAN N.

PUAJ Public notification under rule 129 epc

Free format text: ORIGINAL CODE: 0009425

32PN Public notification

Free format text: INVITATION TO GIVE NOTICE OF APPOINTMENT OF A PROFESSIONAL REPRESENTATIVE (EPO FORM 2502B DATED 12.01.2012) SENT TO RICH, IVAN N. 4405 N. CHESTNUT STREET, SUITE D COLORADO SPRINGS, COLORADO 80

PUAJ Public notification under rule 129 epc

Free format text: ORIGINAL CODE: 0009425

32PN Public notification

Free format text: INVITATION TO GIVE NOTICE OF APPOINTMENT OF A PROFESSIONAL REPRESENTATIVE (EPO FORM 2502B DATED 30/05/2012)

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110617